12 Oncolytic vaccinia (Olvi-Vec) primed immunochemotherapy in platinum-resistant/refractory ovarian cancer
R. W. Holloway(AdventHealth Tampa), S Ahmad(AdventHealth Tampa), Monica M. King(Gynecologic Oncology Associates), Christine Fitzsimmons(AdventHealth Tampa), Kristina M. Mori(Gynecologic Oncology Associates), Andrew Stephens(University of Michigan), Jessica A. Kennard(AdventHealth Tampa), Lisa N. Abaid(Gynecologic Oncology Associates), Jane LeBlanc(AdventHealth Tampa), Madhavi Manyam(AdventHealth Tampa), Nathalie D. McKenzie(AdventHealth Tampa), Alberto A. Mendivil(Gynecologic Oncology Associates), John V. Brown(Gynecologic Oncology Associates), K. Lopez(Gynecologic Oncology Associates), James E. Kendrick(AdventHealth Tampa)
Cited by 5
Related Papers
Effectiveness of 0.08 molar iodine in ethanol solution as a means of chemical surface passivation for photoconductance decay measurements
|Solar Energy Materials and Solar Cells|1997|79
Machine learning-based cytokine microarray digital immunoassay analysis
|Biosensors and Bioelectronics|2021|56
A digital protein microarray for COVID-19 cytokine storm monitoring
|Lab on a Chip|2020|45
Guidelines for investigation of the alpha and beta thalassaemia traits. The Thalassaemia Working Party of the BCSH General Haematology Task Force.
|Journal of Clinical Pathology|1994|44
A tissue chip with integrated digital immunosensors: In situ brain endothelial barrier cytokine secretion monitoring
|Biosensors and Bioelectronics|2022|32